Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.
about
Low dose naltrexone for induction of remission in Crohn's diseaseLow dose naltrexone for induction of remission in Crohn's diseaseThe Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A ReviewNigella sativa (black cumin) seed extract alleviates symptoms of allergic diarrhea in mice, involving opioid receptorsLow-dose naltrexone therapy improves active Crohn's diseaseOpioids and the skin--where do we stand?Opioids: Modulators of angiogenesis in wound healing and cancer.Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.Morphine induces μ opioid receptor endocytosis in guinea pig enteric neurons following prolonged receptor activationMorphine attenuates apically-directed cytokine secretion from intestinal epithelial cells in response to enteric pathogens.Mu opioid signaling protects against acute murine intestinal injury in a manner involving Stat3 signalingActivation of μ opioid receptors modulates inflammation in acute experimental colitis.Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.Disruption of gut homeostasis by opioids accelerates HIV disease progressionOpioids and the gut: pharmacology and current clinical experience.RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectivesmicro-Opioid receptor activation prevents acute hepatic inflammation and cell death.Differential Effectiveness of Clinically-Relevant Analgesics in a Rat Model of Chemotherapy-Induced Mucositis.Gallotannin-Enriched Extract Isolated from Galla Rhois May Be a Functional Candidate with Laxative Effects for Treatment of Loperamide-Induced Constipation of SD RatsLactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study.Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice.Anti-inflammatory effects of Lacto-Wolfberry in a mouse model of experimental colitis.Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gammaGlafenine-induced intestinal injury in zebrafish is ameliorated by μ-opioid signaling via enhancement of Atf6-dependent cellular stress responsesHepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.Morphine induces splenocyte trafficking into the CNS.Effects of methylnaltrexone on guinea pig gastrointestinal motility.Emerging neuropeptide targets in inflammation: NPY and VIPEndogenous analgesia mediated by CD4(+) T lymphocytes is dependent on enkephalins in miceMultidrug resistance-associated transporter 2 regulates mucosal inflammation by facilitating the synthesis of hepoxilin A3.Battle of animal models.Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse.Peripheral mechanisms of pain and analgesia.Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in miceCEACAM1 and the regulation of mucosal inflammation.The endogenous cannabinoid system protects against colonic inflammation.Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives.Opioids for the treatment of arthritis pain.Successful Treatment with Methylnaltrexone and IVIG for Paraneoplastic Syndrome-Associated Intestinal Pseudo-Obstruction.Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications.
P2860
Q24200319-A15B714B-9B5E-4008-B589-E59259A0EC5BQ24201218-A9155226-C0AA-4A73-847D-6D93349EBB83Q26851158-9622D7BA-EA6F-4411-B712-74ACF3C78269Q27300141-0F0CE60A-ED08-4AEC-9CC9-43EA4E844E30Q28283321-5E9E2CD2-013A-4761-9C03-C49DE7A36DDFQ33347020-F8E834A9-817C-49BD-BDA6-40541AB459E9Q33649031-C1F3222A-A0BE-4D30-A8FB-8492DF3F64F3Q34233126-75180190-48B0-44A1-8F3E-2D2081052A28Q34551407-D2349233-B286-428F-82AF-BCD10CF49C71Q34569178-EB0C3204-3FB4-41C7-9B5C-B25D364DF280Q35168195-0B3E5F16-5684-4C5A-9AA3-B7B121D991BDQ35510067-A751AB08-3C31-4A90-8BAD-616CCEAE8CFAQ35760524-4179D82D-DCAA-4C0B-A94B-BA31FE831950Q35782918-A5C4B5AA-56EC-44DB-BED8-AC5203A93899Q35860904-E6554780-0D0F-4541-AE6E-AEA01DA8F526Q35906057-3E4C2409-844D-4A86-BCF7-8DBD4E3A659CQ36014007-A012711A-F8BF-44D6-BCE1-58F1619CB869Q36087227-CD8AB968-03BA-4D63-A420-A688F92E7310Q36130003-6A734CF0-4FAF-434D-A78C-9A39DAD47210Q36185519-3AB510DA-D16D-47FC-A991-9EBF664057EEQ36227327-6146BE4D-DCD3-40A2-895D-4FCB8611B642Q36316681-A3708379-145E-4DAB-A301-F558F4BC6623Q36403491-8524F652-B47D-49BA-8417-0E381DF5B73CQ36486032-3C64686B-C4A2-4ADE-BA73-69EF4009BC16Q36503299-1A7A371D-3290-475F-93DF-BDB792577AECQ36603264-5AD3D251-587B-4CCF-8BA6-2FD9DC4673F3Q36854395-30FAF3D1-2742-442E-AA0D-D711739B448DQ36923640-CBB0E635-1BB4-4EDF-B8AF-3A028108D508Q36955485-F13E5D96-B4AB-4A08-842A-EDA0DFB52255Q37000714-7A7FBC3C-3D92-4F48-B734-7213C5E43D71Q37015533-DE896000-B02B-4234-B58F-6E3A27BE7AA1Q37116354-724DDF3A-80BA-4CF1-AC8D-9A0CE9016D16Q37314270-B51A24E0-D67F-47FA-8CDF-C2B4A6EB09A9Q37340687-7AF2A26E-C904-476B-9A97-39267C3CECA4Q37349774-A1491857-082D-4CE0-8B18-95A4AAC75965Q37370275-0A3868BD-535F-43A2-923F-6A3CCF42ABFBQ37491434-338F056E-9484-4547-9F43-14A82CE2C9B6Q38166805-B85593E4-1D2B-43A0-AE1D-82F5F32227B5Q38618026-25C72436-9FAE-4E4C-8CE1-39B383B96DFCQ38911748-5F93824C-821D-4098-8BE7-72B995309E41
P2860
Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Anti-inflammatory properties o ...... eatment of colon inflammation.
@en
Anti-inflammatory properties o ...... eatment of colon inflammation.
@nl
type
label
Anti-inflammatory properties o ...... eatment of colon inflammation.
@en
Anti-inflammatory properties o ...... eatment of colon inflammation.
@nl
prefLabel
Anti-inflammatory properties o ...... eatment of colon inflammation.
@en
Anti-inflammatory properties o ...... eatment of colon inflammation.
@nl
P2093
P2860
P356
P1476
Anti-inflammatory properties o ...... eatment of colon inflammation.
@en
P2093
Brigitte L Kieffer
Claire Gaveriaux-Ruff
David Philippe
Hervé Groux
Laurent Dubuquoy
Myriam Tran Van Chuoï-Mariot
Valérie Brun
P2860
P304
P356
10.1172/JCI200316750
P407
P577
2003-05-01T00:00:00Z